• Product Name
  • Product Keyword
  • Product Model
  • Product Summary
  • Product Description
  • Multi Field Search
Share to:

Raw Material, Carbidopa,38821-49-7,Fast Delivery

CAS NO:38821-49-7 | Molecular formula:C10H16N2O5

Carbidopa and Levodopa extended release tablets are extended release combination of Carbidopa and Levodopa for the treatment of Parkinson’s disease and syndrome.Carbidopa is a dopa decarboxylase inhibitor, so pr vents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.
  • Carbidopa
  • 99%Min
  • Pharmaceutical Grade

Carbidopa with strong outer peripheral dopa decarboxylase inhibitors. Easy through the blood-brain barrier, in combination with levodopa, suppress only the outer peripheral dopa decarboxylase activity, reducing the generation of dopamine in peripheral tissues, reduce adverse reactions outer periphery, thereby enabling an increase in levodopa into the hub, improve brain dopamine concentration, enhance the efficacy of levodopa, it is an important adjunct to levodopa.



Contact Us

   Ronghua international building , Qujiang administrative business center, Xi'an,Shaanxi,China 710000

   +86-029-68889729
Copyright © 2018 Shaanxi Iknow Biotechnology Co.,Ltd. All rights reserved.
Supported by Leadong   Sitemap